data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
MediWound
(NASDAQ:MDWD)
1.59
0.04[2.58%]
At close: Jun 24
1.29
-0.3000[-18.87%]
After Hours: 4:52PM EDT
Day High/Low1.48 - 1.71
52 Week High/Low1.21 - 6.22
Open / Close1.56 / 1.59
Float / Outstanding20.3M / 33.1M
Vol / Avg.153.3K / 92.5K
Mkt Cap52.7M
P/E-
50d Avg. Price1.86
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float20.3M

MediWound (NASDAQ:MDWD), Quotes and News Summary

MediWound (NASDAQ: MDWD)

Day High/Low1.48 - 1.71
52 Week High/Low1.21 - 6.22
Open / Close1.56 / 1.59
Float / Outstanding20.3M / 33.1M
Vol / Avg.153.3K / 92.5K
Mkt Cap52.7M
P/E-
50d Avg. Price1.86
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float20.3M
Benzinga - May 25, 2022, 4:05PM
Benzinga - May 18, 2022, 7:32AM
Benzinga - May 17, 2022, 7:04AM
Benzinga - May 17, 2022, 7:03AM
Benzinga - May 12, 2022, 7:33AM
Benzinga - May 12, 2022, 7:01AM
Benzinga - Apr 21, 2022, 11:55AM
Benzinga - Mar 21, 2022, 12:05PM
Benzinga - Mar 21, 2022, 7:32AM
Benzinga - Mar 17, 2022, 7:19AM
Benzinga - Mar 3, 2022, 8:57AM
Benzinga - Mar 3, 2022, 8:32AM
Benzinga - Mar 2, 2022, 4:26PM
Benzinga - Feb 17, 2022, 6:12AM
Benzinga - Feb 10, 2022, 10:45AM
Benzinga - Feb 10, 2022, 7:15AM
Benzinga - Jan 24, 2022, 7:46AM
Benzinga - Jan 24, 2022, 7:13AM
Benzinga - Jan 24, 2022, 6:03AM
Benzinga - Jan 5, 2022, 11:16AM
Benzinga - Dec 20, 2021, 7:11AM
load more
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. Its first biopharmaceutical product, NexoBrid removes dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns also referred to as severe burns. NexoBrid is currently in clinical development in North America and is in the process of preparing its Biologics License Application. The company derives its revenue from the United States.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-09
REV
Q1 2022Est.ActualSurprise
EPS-0.110-0.120 -0.0100
REV4.290M4.407M117.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

MediWound Questions & Answers

Q
How do I buy MediWound (MDWD) stock?
A

You can purchase shares of MediWound (NASDAQ: MDWD) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are MediWound's (MDWD) competitors?
A

There are no as such competitors for MediWound.

Q
What is the target price for MediWound (MDWD) stock?
A

The latest price target for MediWound (NASDAQ: MDWD) was reported by Wells Fargo on Wednesday, May 18, 2022. The analyst firm set a price target for 8.00 expecting MDWD to rise to within 12 months (a possible 403.14% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for MediWound (MDWD)?
A

The stock price for MediWound (NASDAQ: MDWD) is $1.59 last updated June 24, 2022, 8:00 PM UTC.

Q
Does MediWound (MDWD) pay a dividend?
A

There are no upcoming dividends for MediWound.

Q
When is MediWound (NASDAQ:MDWD) reporting earnings?
A

MediWound’s Q2 earnings are confirmed for Tuesday, August 9, 2022.

Q
Is MediWound (MDWD) going to split?
A

There is no upcoming split for MediWound.

Q
What sector and industry does MediWound (MDWD) operate in?
A

MediWound is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.